Date: April 14, 2020
Time: 2:00 - 3:30 p.m.
Nixon Peabody partner Hannah Bornstein will speak on the topic "FDA’s Recent COVID-19 Guidances Facilitating Expanded Access to Certain Medical Products," on a complimentary webinar sponsored by the Food and Drug Law Institute (FDLI).
FDA recently issued an array of COVID-19-related guidance documents that facilitate expanded availability of certain medical products during the current public health emergency through enforcement discretion and other temporary policies. These products include diagnostics, personal protective equipment, remote monitoring devices, ventilators, disinfectant devices, and hand sanitizers. This webinar will examine the scope of these guidances, their impact on regulated companies, and how they relate to other FDA requirements, such as Emergency Use Authorizations.
For more information, or to register, please visit the FDLI website.